Skip to main content
KMC Speciality Hospitals India Limited logo

KMC Speciality Hospitals India Limited — Investor Relations & Filings

Ticker · 524520 ISIN · INE879K01018 LEI · 335800546GEXCJ7GCZ28 BSE.NS Human health and social work activities
Open in API
Filings indexed 6 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country IN India
Listing BSE.NS 524520

About KMC Speciality Hospitals India Limited

https://www.kauveryhospital.com

KMC Speciality Hospitals India Limited is a healthcare provider focused on delivering comprehensive tertiary medical services. Based in Tiruchirappalli, the institution operates as a multi-specialty hospital offering advanced diagnostic and therapeutic interventions. Core clinical departments include cardiology, nephrology, urology, gastroenterology, orthopaedics, and neurology. The facility is equipped with modern intensive care units, surgical theaters, and emergency departments to handle complex medical cases. The hospital emphasizes patient-centric care through a multidisciplinary approach, integrating specialized medical expertise with advanced technology. Its service portfolio extends to radiology, pathology, and pharmacy services, catering to a diverse patient demographic seeking specialized treatment in regional healthcare hubs.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 24A of SEBI (LODR) Regulations, 2015, please find enclosed the Annual Secretarial Compliance Report of the Company for the financial year ended March 31, 2026 duly ....
Regulatory Filings Classification · 91% confidence The document is an Annual Secretarial Compliance Report prepared under SEBI (LODR) Regulation 24A and submitted to the stock exchange. It is a compliance certificate signed by the Practicing Company Secretary, containing no substantive financial statements or management analysis. It is primarily an attestation/certification, not a full report like an Annual Report (10-K) or Interim Report (IR). Under the Certification Rule, such officer certifications and regulatory compliance submissions should be classified as Regulatory Filings (RNS).
2026-05-29 English
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Purchase of vacant land by the Company
Regulatory Filings Classification · 85% confidence The document is a stock exchange disclosure under SEBI LODR Regulation 30 announcing a Board-approved land acquisition and its funding plan. It is not a full financial report, management discussion, dividend notice, director dealing, or specific form-based filing. It serves as a general regulatory announcement of a material event, fitting the Regulatory Filings (RNS) category as a fallback for miscellaneous compliance disclosures.
2026-05-29 English
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Appointment of Internal Auditor for FY 2026-27
Regulatory Filings Classification · 80% confidence The document is an exchange filing under Regulation 30 of SEBI LODR notifying the appointment of internal auditors. It does not constitute a full financial report, annual/interim report, or director management change. It is a routine regulatory announcement for continuous disclosure, so it falls under general Regulatory Filings (RNS).
2026-05-29 English
Please find enclosed the Standalone Audited Financial Results for the FY 2025-26
Interim / Quarterly Report Classification · 85% confidence The document is a Board meeting outcome filing under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, including the Independent Auditor’s Report and the full Statement of Audited Financial Results for the year ended March 31, 2026 together with the unaudited quarterly results for Q4. It contains substantive financial statements and auditor opinion—not merely a brief highlights announcement (ER) or an officer certification (RNS/RPA), nor a full annual report (10-K). This aligns with our definition of an Interim/Quarterly Report (IR). FY 2026
2026-05-29 English
Please find enclosed the Standalone Audited Financial results for the Quarter and Year ended 31st March, 2026 along with the Auditors Report as approved by the Board of Directors at their ....
Interim / Quarterly Report Classification · 75% confidence The document is a formal filing to BSE under SEBI LODR Regulation 33 announcing the Standalone Audited Financial Results for the quarter and year ended March 31, 2026, together with the Independent Auditor’s Report and a detailed results table. This is not a full Annual Report (10-K), nor a simple announcement that a report is published (RPA), but rather the actual financial results release containing substantive data for Q4 (which in India includes year-end figures). Therefore it best fits the “Interim / Quarterly Report” category. FY 2026
2026-05-29 English
KMC Speciality Hospitals (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve The Audited ....
Regulatory Filings Classification · 85% confidence The document is a compliance announcement to the stock exchange under SEBI Listing Regulations informing of a scheduled Board meeting to approve audited financial results. It does not itself contain financial statements or results, nor is it a proxy statement or report publication notice, but a regulatory filing. As such it falls under the general “Regulatory Filings” category (RNS).
2026-05-25 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.